Pattern of Antibody Response against the V3 Loop in Children with Vertically Acquired Immunodeficiency Virus Type 1 (HIV-1 Infection
- 1 March 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 9 (3) , 221-228
- https://doi.org/10.1089/aid.1993.9.221
Abstract
The principal neutralizing domain (PND) of HIV-1, located within the third variable region (V3) of the gp120 envelope protein, is related to the humoral and cellular immune response. We studied the V3 PND-specific antibody response in 30 children with vertically acquired HIV-1 infection by determining the antibodies that bound synthetic peptides derived from the PND of the HIV-1MN, HIV-1SF-2, HIV-1SC, HIV-1IIIB, HIV-1RF, HIV-1ELI, and HIV-1Z6 virus strains. At a standard antigen concentration, we found that most sera (90%) reacted against PNDMN peptide, but 73.3% also cross-reacted against multiple PNDs. A search for high-affinity/ avidity antibodies was conducted in an antigen-limited assay; at lower peptide concentrations, cross-reactivity was restricted to PNDMN and PNDSC in 12 of 22 broadly reactive sera. Sequence analysis of the V3 region of HIV-1 isolates indicated that patients with high-affinity/avidity antibodies to PNDMN and PNDSC had a PND with an internal 12-amino acid sequence (serotype-specific domain, SSD) that was highly homologous (>90%) with the MN and SC SSD. Broadly reactive sera with low-affinity/avidity antibodies showed a lower degree of homology with the SSD sequence of all tested viral strains. The role of anti-PND antibodies in vertical transmission was further studied in 49 children born to HIV-1-seropositive mothers. No statistical correlation emerged between V3 antibodies and HIV-1 transmission, but we found that maternal V3 antibodies were lost soon after birth. This finding may be relevant to a new serological approach to the early diagnosis of vertically transmitted HIV-1 infection.Keywords
This publication has 36 references indexed in Scilit:
- Synergistic Neutralization of HIV-1 by Human Monoclonal Antibodies Against the V3 Loop and the CD4-Binding Site of gp120AIDS Research and Human Retroviruses, 1992
- Perinatal infection by human immunodeficiency virus type 1 (HIV–1): Relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcomeJournal of Medical Virology, 1991
- High risk of HIV-1 infection for first-born twinsThe Lancet, 1991
- Advances and problems in the diagnosis of human immunodeficiency virus infection in infantsThe Pediatric Infectious Disease Journal, 1991
- Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infectionAIDS, 1991
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- C-Terminal Fragments of gpl20 and Synthetic Peptides from Five HTLV-III Strains: Prevalence of Antibodies to the HTLV-III-MN Isolate in Infected IndividualsAIDS Research and Human Retroviruses, 1990
- Predominance of HIV-1 serotype distinct from LAV-1/HTLV-IIIBThe Lancet, 1990
- Antibodies from Human Immunodeficiency Virus-Infected Individuals Bind to a Short Amino Acid Sequence that Elicits Neutralizing Antibodies in AnimalsAIDS Research and Human Retroviruses, 1989
- Type-Restricted Neutralization of Molecular Clones of Human Immunodeficiency VirusScience, 1988